Definitive Contract W911S607C0004

<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by a U.S. government agency to Provid Pharmaceuticals Inc., a for-profit organization, in the amount of $199,922.00. The contract is for &quot;Medicinal Chemistry Lead Optimization&quot; research, with a completion date of June 29, 2007. The contract is a Firm Fixed Price Definitive Contract, with the place of performance being North Brunswick Township, NJ.</p>

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to TDA Research, Inc., a small business subchapter S corporation based in Wheat Ridge, Colorado. The contract, valued at $1,099,997.54, is for the second year of an SBIR Phase II effort focused on Topic A19-022. The contract has a total small business set-aside designation. TDA Research is a well-established federal contractor that specializes in...

This is a $224,982.07 Firm Fixed Price SBIR Phase I contract awarded by the National Institute on Drug Abuse (NIDA) to CFD Research Corporation, a small business specializing in engineering simulations and innovative designs. The contract is for the &quot;SMARTPLATE TECHNOLOGY FOR ADVANCED CELLULAR MODELS (STAC-M)&quot; program, which is focused on developing advanced cellular models. The contract has a completion date of February 14, 2017 and was awarded on May 12, 2016. CFD Research has...

This is a $1,099,999.92 Firm Fixed Price SBIR Phase II contract awarded by the Joint PEO Chemical and Biological Defense, a component of the U.S. Army, to Consegna Pharma Inc., a small disadvantaged business. The contract is for the development of a long-duration opioid overdose antagonist. This award follows a prior $167,421 SBIR Phase I contract Consegna received from the Army for additional pharmaceutical research and development. Consegna has also received several grants from the National...

The U.S. government agency awarded a Small Business Innovation Research (SBIR) Program Phase I action contract to Aphios Corp, a minority-owned for-profit organization, for the development of anticancer agents. The fixed-price contract, valued at $149,558.00, was awarded on September 30, 2008, with a completion date of May 31, 2009. The contract was a result of a request for proposal (RFP) titled &quot;DEVELOPMENT OF ANTICANCER AGENTS&quot; and was assigned the solicitation number...

This is a $82,499.02 firm fixed-price contract awarded by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), a defense agency, to Brhms LLC, a woman-owned small business. The contract is for a Small Business Innovation Research (SBIR) Phase I award under Topic #CBD181-007. SBIR Phase I awards fund the exploration of the technical merit or feasibility of an idea or technology. The contract has a completion date of April 14, 2019. This contract is a standalone award...

This is a SBIR Phase I contract awarded by the Department of the Army Medical Command to CFD Research Corporation, a small business, to develop &quot;A Ruggedized Wearable and Sustained Therapeutic Delivery System.&quot; The $249,947.39 firm fixed-price contract was awarded on March 25, 2022 with an end date of October 24, 2022. CFD Research is a small business that provides engineering and R&amp;D services to federal agencies through prime and subcontract awards, including work on medical...

The U.S. National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Celldex Therapeutics, Inc. in the amount of $199,398.00 on September 20, 2012. The contract is for &quot;OTHER FUNCTIONS - R &amp; D BIOMEDICAL (BASIC RESEARCH)&quot; and has a firm fixed price pricing type. The contract has an ultimate completion date of August 23, 2013. This SBIR Phase I award supports basic research and development activities at Celldex Therapeutics, a for-profit small...

The U.S. Army's Joint PEO Chemical and Biological Defense has awarded a $1,099,999.92 Firm Fixed Price contract to Critical Innovations LLC, a small business medical research and development company, for Phase II of a Small Business Innovation Research (SBIR) program effort. The contract is designated as a total small business set-aside. Critical Innovations will continue development of various advanced medical technologies for military and pre-hospital applications, including solutions for...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $149,268.80 Small Business Innovation Research (SBIR) Program Phase I contract to CMC Pharmaceuticals, Inc., a woman-owned small business. This firm fixed price contract is for research and development related to a SBIR topic on chemical/biological defense. As a small business, CMC Pharmaceuticals will provide drug formulation development and complex drug delivery system services to...